TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| AstraZeneca Dealt a Pipeline Setback Zacks.com submits: AstraZeneca (AZN) recently faced a pipeline setback with one of its oncology candidates, Recentin (cediranib). The company announced results from a phase III study (HORIZON II) which was conducted to test Recentin's first-line treatment of metastatic colorectal cancer (mCRC).While Recentin met one of the primary endpoints, which was improvement in progression-free survival, the candidate failed to show an improvement in overall survival. The HORIZON II study compared Recentin plus FOLFOX or XELOX with FOLFOX or XELOX alone.Complete Story » seekingalpha.com |
Bruker Corp. Q2 2010 Earnings Call Transcript Bruker Corp. (BRKR)Q2 2010 Earnings Conference Call July 28, 2010 10:00 am ETComplete Story » seekingalpha.com |
Alliance HealthCare Services Announces Completion of Exchange Offer of Its 8.00% Senior Notes for Registered Notes (Business Wire) NEWPORT BEACH, Calif.----Alliance HealthCare Services, Inc. , a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced today that it has completed its offer to exchange up to $190 million aggregate principal amount of its 8.00% series B senior notes due 2016 which have been registered under the Securities Act of 1933, as amended, for any and all of its outstanding 8.00% senior notes due 2016 which were issued in a private placement . us.rd.yahoo.com |
Justices Wrestle With Vaccine Case The Supreme Court wrestled with the potential consequences of a case that asks the justices to decide whether federal law shields vaccine makers from some types of product-liability lawsuits. online.wsj.com |
Seeking New Blood-Bank Test Scientists are racing to develop tests for a retrovirus linked to chronic fatigue syndrome called XMRV, which could be used to determine if the blood supply is tainted.. online.wsj.com |